Perthera: Perthera to Unveil Breakthrough AI-Driven Predictor for Pancreatic Cancer Treatment
Perthera, a leader in precision oncology, will present follow-on research and validation of the world's first AI-driven chemo predictor for frontline treatment in pancreatic cancer (PDAC) at the 2025 ASCO Gastrointestinal Cancers Symposium.
Read full article »
Perthera is a Virginia-based AI-powered platform that provides solutions such as clinical decision support and treatment prediction for oncologists.
Read more